MedPath

Effect of ksheerabala taila (101) as nasal instillation & chandraprabha vati as an adjuvent in the management of primary open angle glaucoma.

Phase 2
Not yet recruiting
Conditions
Health Condition 1: H401- Open-angle glaucoma
Registration Number
CTRI/2023/06/054360
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.IOP up to 30 mm Hg

2.normo tensive glaucoma of Intra ocular Pressure less than 21 mm Hg

3.Best corrected visual acuity more than 6/60 and clear media

Exclusion Criteria

all type of posterior angle closure glaucoma & cataract

end stage glaucoma or Optic atrophy

best corrected visual acuity less than 6/60

secondary & developmental glaucoma including exfoliative glaucoma pigmentary glaucoma trauma induced glaucoma inflammatory glaucoma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evaluate the adjuvant effect of Ksheerabala taila Pratimarsha nasya and Chandraprabha Vati in the symptoms of Kaphaja adhimantha (POAG).Timepoint: 8 week
Secondary Outcome Measures
NameTimeMethod
evaluate the adjuvant effect of Ksheerabala taila Pratimarsha nasya & Chandraprabha Vati in the management of Kaphaja adhimantha(POAG) of visual symptomsTimepoint: 8 weeks
© Copyright 2025. All Rights Reserved by MedPath